(Q40392276)

20 September 2017

title

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial (English)

1 reference

20 September 2017

0 references

5

John Oxford

1 reference

20 September 2017

Robert Lambkin-Williams

6

object named as

Rob Lambkin-Williams

1 reference

20 September 2017

9

Maria Zambon

1 reference

20 September 2017

Suzanne Jones

1

1 reference

20 September 2017

Kirsten Evans

2

1 reference

20 September 2017

Hilary McElwaine-Johnn

3

1 reference

20 September 2017

Michaela Sharpe

4

1 reference

20 September 2017

Tim Mant

7

1 reference

20 September 2017

Andrew Nolan

8

1 reference

20 September 2017

Joanna Ellis

10

1 reference

20 September 2017

John Beadle

11

1 reference

20 September 2017

Peter T Loudon

12

1 reference

20 September 2017

language of work or name

English

0 references

publication date

24 February 2009

1 reference

20 September 2017

1 reference

20 September 2017

volume

27

1 reference

20 September 2017

issue

18

1 reference

20 September 2017

page(s)

2506-2512

1 reference

Vaccines for seasonal and pandemic influenza.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Influenza vaccine: the challenge of antigenic drift.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Rapid-response vaccines--does DNA offer a solution?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Epidermal DNA vaccine for influenza is immunogenic in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

DNA-based immunization by in vivo transfection of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

T cell responses are better correlates of vaccine protection in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.061

10.1016/J.VACCINE.2009.02.061

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference